Apatinib Plus Irinotecan as Second-line Treatment in AGC or EGJA
Clinical trial NCT03116555 · UNKNOWN
Trial details
- NCT number
- NCT03116555
- Sponsor
- China Medical University, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-05
- Primary completion
- 2020-03-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.